Home › Compare › MLPH vs DIVO

MLPH vs DIVO: Dividend Comparison 2026

MLPH yields 250000.00% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLPH wins by $4.567699004441311e+30M in total portfolio value
10 years
MLPH
MLPH
● Live price
250000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.567699004441311e+30M
Annual income
$4,564,107,688,187,857,300,000,000,000,000,000,000.00
Full MLPH calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — MLPH vs DIVO

📍 MLPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLPHDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLPH + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MLPH pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLPH
Annual income on $10K today (after 15% tax)
$21,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,879,491,534,959,678,500,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, MLPH beats the other by $3,879,491,534,959,678,500,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLPH + DIVO for your $10,000?

MLPH: 50%DIVO: 50%
100% DIVO50/50100% MLPH
Portfolio after 10yr
$2.2838495022206556e+30M
Annual income
$2,282,053,844,093,928,700,000,000,000,000,000,000.00/yr
Blended yield
99.92%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLPH buys
0
DIVO buys
0
No recent congressional trades found for MLPH or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLPHDIVO
Forward yield250000.00% ✓6.62%
Annual dividend / share$2.00$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.567699004441311e+30M$31.0K ✓
Annual income after 10y$4,564,107,688,187,857,300,000,000,000,000,000,000.00 ✓$1,008.47
Total dividends collected$4.567463897060879e+30M$8.4K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MLPH vs DIVO ($10,000, DRIP)

YearMLPH PortfolioMLPH Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$25,010,700$25,000,000.00$11,362$661.96+$25.00M → MLPH
2$58,462,976,402$58,436,214,953.27$12,860$702.91+$58462.96M → MLPH
3$127,722,124,784,416$127,659,569,399,665.92$14,504$743.56+$127722124.77M → MLPH
4$260,784,910,907,288,130$260,648,248,233,768,800.00$16,303$783.73+$260784910907.27M → MLPH
5$497,657,939,618,196,950,000$497,378,899,763,526,240,000.00$18,268$823.31+$497657939618196.94M → MLPH
6$887,590,576,640,622,200,000,000$887,058,082,645,230,600,000,000.00$20,408$862.17+$887590576640622208.00M → MLPH
7$1,479,547,418,610,237,200,000,000,000$1,478,597,696,693,231,600,000,000,000.00$22,737$900.20+$1.4795474186102372e+21M → MLPH
8$2,305,052,548,351,757,200,000,000,000,000$2,303,469,432,613,844,500,000,000,000,000.00$25,266$937.31+$2.3050525483517572e+24M → MLPH
9$3,356,370,330,330,650,300,000,000,000,000,000$3,353,903,924,103,914,000,000,000,000,000,000.00$28,008$973.42+$3.3563703303306504e+27M → MLPH
10$4,567,699,004,441,311,000,000,000,000,000,000,000$4,564,107,688,187,857,300,000,000,000,000,000,000.00$30,977$1,008.47+$4.567699004441311e+30M → MLPH

MLPH vs DIVO: Complete Analysis 2026

MLPH — Stock

Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical distributors, and through collaborative dealings with companies in the United States and Europe. It also has an agreement with Dermatology Development Corporation to develop and market a range of therapeutic, cosmetic, and cosmecutical products based on the ThermaLIFE product range and its active ingredient. The company is based in Perth, Australia. Molecular Pharmacology (USA) Limited is a subsidiary of PharmaNet Group Limited.

Full MLPH Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this MLPH vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLPH vs SCHDMLPH vs JEPIMLPH vs OMLPH vs KOMLPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.